Blockade of intracranial self-stimulation by antipsychotic drugs: failure to correlate with central alpha-noradrenergic blockade - PubMed (original) (raw)

Blockade of intracranial self-stimulation by antipsychotic drugs: failure to correlate with central alpha-noradrenergic blockade

P Zarevics et al. Psychopharmacology (Berl). 1977.

Abstract

The involvement of central alpha-noradrenergic receptors in intracranial self-stimulation (ICSS) was studied. Dose-response curves were established for the blockade of ICSS by the antipsychotic drugs chlorpromazine, thioridazine, clozapine, and pimozide and the alpha-antagonist phenoxybenzamine. Antagonism of the facilitation, produced by the central alpha-agonist clonidine, of flexor withdrawal reflexes in the reserpinized spinal rat was used to assess the central alpha-blocking potency of the same drugs, and dose-response curves were established. No correlation was found between central alpha-blockade, as reflected by the ED50 for blockade of clonidine-facilated spinal reflexes, and the ED50 for blockade of ICSS. Pimozide blocked ICSS at doses virtually devoid of central alpha-blocking activity, while phenoxybenzamine was a potent alpha-antagonist and a weak blocker of ICSS. The lack of correlation between central alpha-blockade and decreased ICSS suggests that alpha-receptors are not critically involved in self-stimulation behavior.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Jpn J Pharmacol. 1974 Aug;24(4):613-9 - PubMed
    1. Brain Res. 1972 Jan 28;36(2):385-98 - PubMed
    1. Psychol Med. 1972 Nov;2(4):414-21 - PubMed
    1. Brain Res. 1976 Mar 12;104(2):221-32 - PubMed
    1. Acta Pharmacol Toxicol (Copenh). 1967;25:Suppl 4:5-6 - PubMed

MeSH terms

Substances

LinkOut - more resources